welcome
CNBC

CNBC

Health

Health

Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom

CNBC
Summary
Nutrition label

80% Informative

Eli Lilly CEO Dave Ricks said the drugmaker can help "respond" to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom.

The Trump administration has opened a Section 232 investigation into how importing certain drugs into the U.S. affects national security.

Ricks: "Do I think tariffs are the answer to that? I'm not so sure personally".

VR Score

84

Informative language

84

Neutral language

66

Article tone

semi-formal

Language

English

Language complexity

60

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links